Welcome to our dedicated page for Precision Optics Corporation news (Ticker: POCI), a resource for investors and traders seeking the latest updates and insights on Precision Optics Corporation stock.
Precision Optics Corporation, Inc. (NASDAQ: POCI) is a leading designer and manufacturer of cutting-edge optical instruments, primarily serving the medical, defense, and aerospace industries. Founded in 1982, this Gardner, Massachusetts-based company has cemented its place in the market by leveraging its proprietary micro-optics and advanced 3D imaging technologies.
Core Business: Precision Optics specializes in developing and manufacturing high-quality optical medical devices, including endoscopes and endocouplers, which are crucial for minimally invasive surgical and diagnostic procedures. The company is also known for designing custom optical solutions tailored to meet specific client needs in the medical, industrial, and military sectors.
Recent Achievements: On December 4, 2023, the company announced a significant production and technology license agreement with a leading surgical robotics firm. This agreement involves the supply of a single-use endoscope assembly for cystoscopy robotic surgery systems, a project that emerged from joint developmental efforts over the past 18 months.
Current Projects: Precision Optics is gearing up for the mass production of the single-use endoscope assembly, expected to start within six to twelve months. This new venture aligns with the company's strategic push into the rapidly growing single-use medical device market, a segment experiencing higher growth rates compared to the broader medical device sector.
Financial Condition: The company's latest financial results for Q2 of fiscal year 2024 indicate steady progress. Despite some fluctuations in revenue due to timing differences and new program rollouts, Precision Optics reported a 12% increase in total revenue compared to the previous quarter, driven by record engineering revenue and new production programs.
Partnerships: The company continues to forge strong partnerships within the medical and defense industries. These collaborations are facilitated by Precision Optics' in-house capabilities in design, prototyping, regulatory compliance, and mass manufacturing, supported by its Lighthouse Imaging and Ross Optical divisions.
Products: Within the healthcare sector, Precision Optics focuses on next-generation medical devices, including single-use instruments and 3D endoscopy systems. The company also extends its expertise to the defense and aerospace sectors, delivering high-quality optical components that meet rigorous standards for size, weight, and power optimization.
For more information, please visit www.poci.com.
Precision Optics (NASDAQ: POCI) reported third-quarter fiscal year 2024 results, showing a 4% increase in revenue to $5.2 million from $5.0 million in the same quarter last year. Engineering revenue surged 62% to $2.3 million, while production revenue decreased to $3.0 million from $3.6 million the previous year. Gross margins improved to 35.5% from 34.4%. The net loss narrowed to ($317,055) from ($398,432) last year, and adjusted EBITDA rose to $52,012 from $9,456.
In April and May 2024, the company secured significant production orders, including a $9 million cystoscopy surgery program and orders from major defense contractors totaling nearly $2 million. CEO Joseph Forkey highlighted the company's growth and strategic positioning in the medical devices and defense sectors.
Precision Optics , Inc. (NASDAQ: POCI) announced a record $9 million production order for single-use endoscope assemblies for cystoscopy surgery. This order highlights the company's technological capabilities and growth potential in the single-use medical device market. The order is expected to generate approximately $2.2 million in revenue by June 2025, $4.6 million in fiscal 2026, and the remainder by the first half of fiscal 2027.
Precision Optics , Inc. (Nasdaq: POCI) has scheduled a conference call to discuss third quarter fiscal year 2024 financial results on May 15, 2024. The Company will release its financial results and file its 10-Q after the market closes on the same day. Interested parties can access the call via phone or webcast.
FAQ
What is the current stock price of Precision Optics Corporation (POCI)?
What is the market cap of Precision Optics Corporation (POCI)?
What does Precision Optics Corporation, Inc. specialize in?
What are some of the key products offered by Precision Optics?
What recent achievements has Precision Optics Corporation announced?
What sectors does Precision Optics serve?
What are the company's recent financial highlights?
Who are Precision Optics' partners?
When was Precision Optics Corporation founded?
Where is Precision Optics Corporation headquartered?
What is the focus of Precision Optics in the medical device market?
How can I learn more about Precision Optics Corporation?
